[IUK] Medicines Manufacturing Data Institute: Phase 1
UK organisations can apply for 100% funding to develop the consortium, strategy and Phase 2 proposal required to establish a national Medicines Manufacturing Data Institute. The proposed institute will be a trusted, secure and federated data hub that enables organisations across the medicines development and manufacturing ecosystem to capture, share and use data. Phase 1 projects must develop the institute’s blueprint, governance and data architecture, initial use cases, business model, implementation roadmap and committed delivery consortium.
Next deadline
Date to be confirmed
What it funds
UK organisations can apply for 100% funding to develop the consortium, strategy and Phase 2 proposal required to establish a national Medicines Manufacturing Data Institute. The proposed institute will be a trusted, secure and federated data hub that enables organisations across the medicines development and manufacturing ecosystem to capture, share and use data. Phase 1 projects must develop the institute’s blueprint, governance and data architecture, initial use cases, business model, implementation roadmap and committed delivery consortium.
Who it suits
Established organisations with strong medicines-manufacturing networks and the credibility to convene pharmaceutical manufacturers, data owners, technology providers, regulators, researchers and other stakeholders around a national data infrastructure initiative.
- Life sciences & health
- Manufacturing & materials
- Feasibility
- Industrial R&D
Programme specifications
Considering [IUK] Medicines Manufacturing Data Institute: Phase 1?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.